STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE
The present invention relates to a stable pharmaceutical composition for sublingual and/or buccal administration comprising asenapine or pharmaceutically acceptable salt thereof, antioxidant. water-soluble polymer, water soluble diluent, disintegrant and optionally one or more pharmaceutically accep...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LALANI, JIGAR RAMESHCHANDRA TADURI, VEERABABU RAMABRAHMMAM VAIDYA, VIRAL RAMESH |
| description | The present invention relates to a stable pharmaceutical composition for sublingual and/or buccal administration comprising asenapine or pharmaceutically acceptable salt thereof, antioxidant. water-soluble polymer, water soluble diluent, disintegrant and optionally one or more pharmaceutically acceptable excipient having improved bioavailability or is bioequivalent to marketed product Saphris®, Sycrest® and process for preparation of same.
La présente invention concerne une composition pharmaceutique stable pour l'administration par voie buccale et/ou sublinguale comprenant de l'asénapine ou un de ses sel pharmaceutiquement acceptable, un antioxydant, un polymère soluble dans l'eau, un diluant soluble dans l'eau, un délitant et éventuellement un ou plusieurs excipients pharmaceutiquement acceptables présentant une biodisponibilité améliorée ou bioéquivalente au produit commercialisé Saphris ®, Sycrest ® et un procédé de préparation de ceux-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2014207664A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2014207664A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2014207664A23</originalsourceid><addsrcrecordid>eNrjZNALDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PdT8HdTcAx29XMM8PRz5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGJkYG5mZmJo5GxsSpAgCFHybC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE</title><source>esp@cenet</source><creator>LALANI, JIGAR RAMESHCHANDRA ; TADURI, VEERABABU RAMABRAHMMAM ; VAIDYA, VIRAL RAMESH</creator><creatorcontrib>LALANI, JIGAR RAMESHCHANDRA ; TADURI, VEERABABU RAMABRAHMMAM ; VAIDYA, VIRAL RAMESH</creatorcontrib><description>The present invention relates to a stable pharmaceutical composition for sublingual and/or buccal administration comprising asenapine or pharmaceutically acceptable salt thereof, antioxidant. water-soluble polymer, water soluble diluent, disintegrant and optionally one or more pharmaceutically acceptable excipient having improved bioavailability or is bioequivalent to marketed product Saphris®, Sycrest® and process for preparation of same.
La présente invention concerne une composition pharmaceutique stable pour l'administration par voie buccale et/ou sublinguale comprenant de l'asénapine ou un de ses sel pharmaceutiquement acceptable, un antioxydant, un polymère soluble dans l'eau, un diluant soluble dans l'eau, un délitant et éventuellement un ou plusieurs excipients pharmaceutiquement acceptables présentant une biodisponibilité améliorée ou bioéquivalente au produit commercialisé Saphris ®, Sycrest ® et un procédé de préparation de ceux-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141231&DB=EPODOC&CC=WO&NR=2014207664A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141231&DB=EPODOC&CC=WO&NR=2014207664A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LALANI, JIGAR RAMESHCHANDRA</creatorcontrib><creatorcontrib>TADURI, VEERABABU RAMABRAHMMAM</creatorcontrib><creatorcontrib>VAIDYA, VIRAL RAMESH</creatorcontrib><title>STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE</title><description>The present invention relates to a stable pharmaceutical composition for sublingual and/or buccal administration comprising asenapine or pharmaceutically acceptable salt thereof, antioxidant. water-soluble polymer, water soluble diluent, disintegrant and optionally one or more pharmaceutically acceptable excipient having improved bioavailability or is bioequivalent to marketed product Saphris®, Sycrest® and process for preparation of same.
La présente invention concerne une composition pharmaceutique stable pour l'administration par voie buccale et/ou sublinguale comprenant de l'asénapine ou un de ses sel pharmaceutiquement acceptable, un antioxydant, un polymère soluble dans l'eau, un diluant soluble dans l'eau, un délitant et éventuellement un ou plusieurs excipients pharmaceutiquement acceptables présentant une biodisponibilité améliorée ou bioéquivalente au produit commercialisé Saphris ®, Sycrest ® et un procédé de préparation de ceux-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNALDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PdT8HdTcAx29XMM8PRz5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGJkYG5mZmJo5GxsSpAgCFHybC</recordid><startdate>20141231</startdate><enddate>20141231</enddate><creator>LALANI, JIGAR RAMESHCHANDRA</creator><creator>TADURI, VEERABABU RAMABRAHMMAM</creator><creator>VAIDYA, VIRAL RAMESH</creator><scope>EVB</scope></search><sort><creationdate>20141231</creationdate><title>STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE</title><author>LALANI, JIGAR RAMESHCHANDRA ; TADURI, VEERABABU RAMABRAHMMAM ; VAIDYA, VIRAL RAMESH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2014207664A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LALANI, JIGAR RAMESHCHANDRA</creatorcontrib><creatorcontrib>TADURI, VEERABABU RAMABRAHMMAM</creatorcontrib><creatorcontrib>VAIDYA, VIRAL RAMESH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LALANI, JIGAR RAMESHCHANDRA</au><au>TADURI, VEERABABU RAMABRAHMMAM</au><au>VAIDYA, VIRAL RAMESH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE</title><date>2014-12-31</date><risdate>2014</risdate><abstract>The present invention relates to a stable pharmaceutical composition for sublingual and/or buccal administration comprising asenapine or pharmaceutically acceptable salt thereof, antioxidant. water-soluble polymer, water soluble diluent, disintegrant and optionally one or more pharmaceutically acceptable excipient having improved bioavailability or is bioequivalent to marketed product Saphris®, Sycrest® and process for preparation of same.
La présente invention concerne une composition pharmaceutique stable pour l'administration par voie buccale et/ou sublinguale comprenant de l'asénapine ou un de ses sel pharmaceutiquement acceptable, un antioxydant, un polymère soluble dans l'eau, un diluant soluble dans l'eau, un délitant et éventuellement un ou plusieurs excipients pharmaceutiquement acceptables présentant une biodisponibilité améliorée ou bioéquivalente au produit commercialisé Saphris ®, Sycrest ® et un procédé de préparation de ceux-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2014207664A2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | STABLE PHARMACEUTICAL COMPOSITION OF ASENAPINE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LALANI,%20JIGAR%20RAMESHCHANDRA&rft.date=2014-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2014207664A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |